Is Sprout Legit? The Honest Audit of a Newer GLP-1 Provider (2026)

For a provider like Medvi, the legitimacy question is settled by fourteen thousand public reviews. Sprout doesn't have that dataset - it publishes no aggregate Trustpilot score - so the honest audit runs on three other tests: does the clinical process have a real gate, do the published prices survive contact with the checkout page, and do the reviews that DO exist describe a functioning operation or a mailbox company?

Sprout passes the first test the way every legitimate telehealth provider does: an online medical intake reviewed by a licensed provider who decides whether GLP-1 treatment is appropriate. Prescription medication only - there's no "skip the doctor" path, which is exactly what you want to see. If prescribed, the medication ships within 2 days of approval.

Sprout's visible customer reviews are individually verifiable and strikingly consistent about one thing: the support team responds, fast, and by name. "They were quick to respond and the process for approval worked seamlessly. Customer service was awesome, shout out to Frank!" writes one customer. Another: "Super easy to join, reasonably priced, effective, and great customer service. Frank Burton with customer support was really helpful and quick to respond." A third: "When I have had questions or problems their support staff is very quick to respond."

Read skeptically, that's a small sample - and we'd say so if the pattern were mixed. But the same named rep appearing across independent reviews is the signature of an actual, reachable support operation. What Sprout lacks is scale of evidence, not quality of it: there is no published aggregate score, so you can't verify the experience across thousands of customers the way you can at wellmedr (4.7 across 1,205) or Medvi (4.4 across 14,372).

Sprout's published structure is simple and holds: compounded semaglutide from $149/month, compounded tirzepatide from $199/month, and - genuinely unusual for a mid-tier provider - brand-name Wegovy from $1,799/month. A standing offer takes $200 off the first month. No teaser rate that balloons after month one (that's trimrx's structure, where $179 becomes $299), though Sprout publishes fewer plan-term details than rivals - commitment and cancellation specifics are worth confirming at checkout.

Yes, with the caveats stated plainly: licensed-provider review before any prescription, published prices that hold, 2-day fulfillment, and reviews that describe reachable, named humans. What it can't yet offer is large-scale public proof - no aggregate score, no million-patient claim - so risk-averse buyers may prefer a provider with a bigger published record. If you go with Sprout, you're trading evidence-at-scale for speed, personalization and the Wegovy option.

→ Read the full Sprout review: plans, pricing and real customer feedback

→ How Sprout stacks up against embody's $69 flat price

This article is general information, not medical advice.